Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment.

Herfarth H, Barnes EL, Long MD, Isaacs KL, Leith T, Silverstein M, Gerardin Y, Kassam Z.

Inflamm Intest Dis. 2019 May;4(1):1-6. doi: 10.1159/000497042. Epub 2019 Mar 29.

PMID:
31172007
2.

Increased Prevalence of Esophageal Eosinophilia in Patients with Inflammatory Bowel Disease.

Fan YC, Steele D, Kochar B, Arsene D, Long MD, Dellon ES.

Inflamm Intest Dis. 2019 Apr;3(4):180-186. doi: 10.1159/000497236. Epub 2019 Mar 20.

3.

Association Between Vulvovaginal Discomfort and Activity of Inflammatory Bowel Diseases.

Ona S, James K, Ananthakrishnan AN, Long MD, Martin C, Chen W, Mitchell CM.

Clin Gastroenterol Hepatol. 2019 May 18. pii: S1542-3565(19)30528-2. doi: 10.1016/j.cgh.2019.05.018. [Epub ahead of print]

PMID:
31108226
4.

Challenges in IBD Research: Pragmatic Clinical Research.

Scott FI, Rubin DT, Kugathasan S, Bousvaros A, Elson CO, Newberry RD, Melmed GY, Pekow J, Fleshman JW, Boyle BM, Mahadevan U, Cannon LM, Long MD, Cross RK, Ha CY, Lasch KL, Robinson AM, Rafferty JF, Lee JJ, Dahl KDC, Weaver A, Shtraizent N, Honig G, Hurtado-Lorenzo A, Heller CA.

Inflamm Bowel Dis. 2019 May 16;25(Supplement_2):S40-S47. doi: 10.1093/ibd/izz085.

PMID:
31095704
5.

Overview of Extraintestinal Manifestations of Inflammatory Bowel Disease.

Long MD.

Gastroenterol Hepatol (N Y). 2019 Mar;15(3):161-163. No abstract available.

6.

Diagnosis and treatment of dermatologic diseases in inflammatory bowel disease.

Brenner EJ, Long MD.

Curr Opin Gastroenterol. 2019 Apr 22. doi: 10.1097/MOG.0000000000000538. [Epub ahead of print]

PMID:
31021924
7.

Histologic Remission in Ulcerative Colitis: Are We There Yet?

Long MD, Rubin DT.

Am J Gastroenterol. 2019 May;114(5):713-715. doi: 10.14309/ajg.0000000000000235.

PMID:
31021831
8.

Impact of Obesity on Disease Activity and Patient-Reported Outcomes Measurement Information System (PROMIS) in Inflammatory Bowel Diseases.

Jain A, Nguyen NH, Proudfoot JA, Martin CF, Sandborn WJ, Kappelman MD, Long MD, Singh S.

Am J Gastroenterol. 2019 Apr;114(4):630-639. doi: 10.14309/ajg.0000000000000197.

PMID:
30865012
9.

A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.

Barnes EL, Kappelman MD, Long MD, Evon DM, Martin CF, Sandler RS.

Am J Gastroenterol. 2019 Apr;114(4):640-647. doi: 10.14309/ajg.0000000000000177.

PMID:
30848727
10.

ACG Clinical Guideline: Ulcerative Colitis in Adults.

Rubin DT, Ananthakrishnan AN, Siegel CA, Sauer BG, Long MD.

Am J Gastroenterol. 2019 Mar;114(3):384-413. doi: 10.14309/ajg.0000000000000152.

PMID:
30840605
11.

Antidepressants in IBD: Healthy Adherer Effect?

Kochar B, Long MD, Herfarth HH.

Inflamm Bowel Dis. 2019 Mar 6. pii: izz036. doi: 10.1093/ibd/izz036. [Epub ahead of print] No abstract available.

PMID:
30838390
12.

High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease.

Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS.

Inflamm Bowel Dis. 2018 Dec 22. doi: 10.1093/ibd/izy378. [Epub ahead of print]

PMID:
30590700
13.

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas.

Rosario SR, Long MD, Affronti HC, Rowsam AM, Eng KH, Smiraglia DJ.

Nat Commun. 2018 Dec 14;9(1):5330. doi: 10.1038/s41467-018-07232-8.

14.

Preventive Medicine in Inflammatory Bowel Disease.

Weaver KN, Long MD.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):824-828. doi: 10.1016/j.cgh.2018.11.054. Epub 2018 Dec 6. No abstract available.

PMID:
30529728
15.

Social Media Use and Preferences in Patients With Inflammatory Bowel Disease.

Reich J, Guo L, Groshek J, Weinberg J, Chen W, Martin C, Long MD, Farraye FA.

Inflamm Bowel Dis. 2019 Feb 21;25(3):587-591. doi: 10.1093/ibd/izy280.

PMID:
30203036
16.

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

Bianchi-Smiraglia A, Bagati A, Fink EE, Affronti HC, Lipchick BC, Moparthy S, Long MD, Rosario SR, Lightman SM, Moparthy K, Wolff DW, Yun DH, Han Z, Polechetti A, Roll MV, Gitlin II, Leonova KI, Rowsam AM, Kandel ES, Gudkov AV, Bergsagel PL, Lee KP, Smiraglia DJ, Nikiforov MA.

J Clin Invest. 2018 Oct 1;128(10):4682-4696. doi: 10.1172/JCI70712. Epub 2018 Sep 10.

17.

Response to Levenstein and Prantera.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 Oct;113(10):1559. doi: 10.1038/s41395-018-0223-4. Epub 2018 Aug 31. No abstract available.

PMID:
30171218
18.

Correction to: Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life.

Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD.

Dig Dis Sci. 2018 Oct;63(10):2816. doi: 10.1007/s10620-018-5250-x.

PMID:
30136046
19.

The miR-96 and RARγ signaling axis governs androgen signaling and prostate cancer progression.

Long MD, Singh PK, Russell JR, Llimos G, Rosario S, Rizvi A, van den Berg PR, Kirk J, Sucheston-Campbell LE, Smiraglia DJ, Campbell MJ.

Oncogene. 2019 Jan;38(3):421-444. doi: 10.1038/s41388-018-0450-6. Epub 2018 Aug 17.

20.

Methotrexate Is Not Superior to Placebo in Maintaining Steroid-Free Response or Remission in Ulcerative Colitis.

Herfarth H, Barnes EL, Valentine JF, Hanson J, Higgins PDR, Isaacs KL, Jackson S, Osterman MT, Anton K, Ivanova A, Long MD, Martin C, Sandler RS, Abraham B, Cross RK, Dryden G, Fischer M, Harlan W, Levy C, McCabe R, Polyak S, Saha S, Williams E, Yajnik V, Serrano J, Sands BE, Lewis JD; Clinical Research Alliance of the Crohn’s and Colitis Foundation.

Gastroenterology. 2018 Oct;155(4):1098-1108.e9. doi: 10.1053/j.gastro.2018.06.046. Epub 2018 Jun 30.

PMID:
29964043
21.

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib.

Winthrop KL, Melmed GY, Vermeire S, Long MD, Chan G, Pedersen RD, Lawendy N, Thorpe AJ, Nduaka CI, Su C.

Inflamm Bowel Dis. 2018 Sep 15;24(10):2258-2265. doi: 10.1093/ibd/izy131.

22.

Lack of Difference in Treatment Patterns and Clinical Outcomes Between Black and White Patients With Inflammatory Bowel Disease.

Barnes EL, Kochar B, Long MD, Pekow J, Ananthakrishnan A, Anyane-Yeboa A, Martin C, Galanko J, Herfarth HH, Kappelman MD, Sandler RS.

Inflamm Bowel Dis. 2018 Nov 29;24(12):2634-2640. doi: 10.1093/ibd/izy179.

PMID:
29788063
23.

Response to Dai et al. and Gracie et al.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 May;113(5):774-775. doi: 10.1038/s41395-018-0037-4. Epub 2018 Apr 23. No abstract available.

PMID:
29681625
24.

Clinical disease activity in the CALM study.

Herfarth H, Long MD, Isaacs KL.

Lancet. 2018 Apr 14;391(10129):1481-1482. doi: 10.1016/S0140-6736(18)30784-0. No abstract available.

PMID:
29676279
25.

Paternal Disease Activity Is Associated With Difficulty in Conception Among Men With Inflammatory Bowel Diseases.

Ananthakrishnan AN, Martin C, Kane S, Sandler RS, Long MD.

Clin Gastroenterol Hepatol. 2019 Jan;17(1):203-204. doi: 10.1016/j.cgh.2018.04.001. Epub 2018 Apr 11.

PMID:
29653290
26.

Contemporary Management of Ulcerative Colitis.

Vanga R, Long MD.

Curr Gastroenterol Rep. 2018 Mar 27;20(3):12. doi: 10.1007/s11894-018-0622-0. Review.

PMID:
29589185
27.

Inflammatory Bowel Diseases Can Adversely Impact Domains of Sexual Function Such as Satisfaction with Sex Life.

Eluri S, Cross RK, Martin C, Weinfurt KP, Flynn KE, Long MD, Chen W, Anton K, Sandler RS, Kappelman MD.

Dig Dis Sci. 2018 Jun;63(6):1572-1582. doi: 10.1007/s10620-018-5021-8. Epub 2018 Mar 21. Erratum in: Dig Dis Sci. 2018 Oct;63(10):2816.

28.

What Is the Role of the Inflammatory Bowel Disease Panel in Diagnosis and Treatment?

Long MD, Sands BE.

Clin Gastroenterol Hepatol. 2018 May;16(5):618-620. doi: 10.1016/j.cgh.2018.02.010. Epub 2018 Feb 15. No abstract available.

PMID:
29454043
29.

When Do You Start and When Do You Stop Screening for Colon Cancer in Inflammatory Bowel Disease?

Long MD, Sands BE.

Clin Gastroenterol Hepatol. 2018 May;16(5):621-623. doi: 10.1016/j.cgh.2018.02.011. Epub 2018 Feb 14. No abstract available.

PMID:
29454042
30.

The Influence of Hormonal Fluctuation on Inflammatory Bowel Disease Symptom Severity-A Cross-Sectional Cohort Study.

Rolston VS, Boroujerdi L, Long MD, McGovern DPB, Chen W, Martin CF, Sandler RS, Carmichael JD, Dubinsky M, Melmed GY.

Inflamm Bowel Dis. 2018 Jan 18;24(2):387-393. doi: 10.1093/ibd/izx004.

31.

Exercise in patients with inflammatory bowel diseases: current perspectives.

Engels M, Cross RK, Long MD.

Clin Exp Gastroenterol. 2017 Dec 22;11:1-11. doi: 10.2147/CEG.S120816. eCollection 2018. Review.

32.

Dietary folate levels alter the kinetics and molecular mechanism of prostate cancer recurrence in the CWR22 model.

Affronti HC, Long MD, Rosario SR, Gillard BM, Karasik E, Boerlin CS, Pellerite AJ, Foster BA, Attwood K, Pili R, Wilton JH, Campbell MJ, Smiraglia DJ.

Oncotarget. 2017 Oct 20;8(61):103758-103774. doi: 10.18632/oncotarget.21911. eCollection 2017 Nov 28.

33.

Minority Pediatric Patients with Inflammatory Bowel Disease Demonstrate an Increased Length of Stay.

Barnes EL, Kochar B, Long MD, Martin CF, Kappelman MD.

Inflamm Bowel Dis. 2017 Dec;23(12):2189-2196. doi: 10.1097/MIB.0000000000001267.

34.

Depression Is Associated With More Aggressive Inflammatory Bowel Disease.

Kochar B, Barnes EL, Long MD, Cushing KC, Galanko J, Martin CF, Raffals LE, Sandler RS.

Am J Gastroenterol. 2018 Jan;113(1):80-85. doi: 10.1038/ajg.2017.423. Epub 2017 Nov 14.

35.

The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease.

Barnes EL, Kochar B, Long MD, Martin CF, Crockett SD, Korzenik JR, Kappelman MD.

J Pediatr. 2017 Dec;191:184-189.e1. doi: 10.1016/j.jpeds.2017.08.042. Epub 2017 Oct 14.

36.

Evaluation of Gastrointestinal Patient Reported Outcomes Measurement Information System (GI-PROMIS) Symptom Scales in Subjects With Inflammatory Bowel Diseases.

Kochar B, Martin CF, Kappelman MD, Spiegel BM, Chen W, Sandler RS, Long MD.

Am J Gastroenterol. 2018 Jan;113(1):72-79. doi: 10.1038/ajg.2017.240. Epub 2017 Aug 29.

PMID:
28853727
37.

The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease.

Ananthakrishnan AN, Sakuraba A, Barnes EL, Pekow J, Raffals L, Long MD, Sandler RS.

Aliment Pharmacol Ther. 2017 Jul;46(2):162-168. doi: 10.1111/apt.14125. Epub 2017 May 3.

38.

Pouch-Related Symptoms and Quality of Life in Patients with Ileal Pouch-Anal Anastomosis.

Barnes EL, Herfarth HH, Sandler RS, Chen W, Jaeger E, Nguyen VM, Robb AR, Kappelman MD, Martin CF, Long MD.

Inflamm Bowel Dis. 2017 Jul;23(7):1218-1224. doi: 10.1097/MIB.0000000000001119.

39.

Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.

Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD.

Inflamm Bowel Dis. 2017 Jun;23(6):875-881. doi: 10.1097/MIB.0000000000001121.

40.

Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.

Kochar B, Long MD, Galanko J, Raffals LE, Ananthakrishnan A, Sandler RS.

Inflamm Bowel Dis. 2017 Jul;23(7):1187-1194. doi: 10.1097/MIB.0000000000001115.

41.

The Genomic Impact of DNA CpG Methylation on Gene Expression; Relationships in Prostate Cancer.

Long MD, Smiraglia DJ, Campbell MJ.

Biomolecules. 2017 Feb 14;7(1). pii: E15. doi: 10.3390/biom7010015. Review.

42.

Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-κB binding that is linked to immune phenotypes.

Singh PK, van den Berg PR, Long MD, Vreugdenhil A, Grieshober L, Ochs-Balcom HM, Wang J, Delcambre S, Heikkinen S, Carlberg C, Campbell MJ, Sucheston-Campbell LE.

BMC Genomics. 2017 Feb 6;18(1):132. doi: 10.1186/s12864-017-3481-4.

43.

Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.

Abdalla MI, Sandler RS, Kappelman MD, Martin CF, Chen W, Anton K, Long MD.

Inflamm Bowel Dis. 2017 Feb;23(2):325-331. doi: 10.1097/MIB.0000000000001017.

PMID:
28092305
44.

Integrative genomic approaches to dissect clinically-significant relationships between the VDR cistrome and gene expression in primary colon cancer.

Long MD, Campbell MJ.

J Steroid Biochem Mol Biol. 2017 Oct;173:130-138. doi: 10.1016/j.jsbmb.2016.12.013. Epub 2016 Dec 24.

PMID:
28027912
45.

miRNAs as drivers of TMPRSS2-ERG negative prostate tumors in African American men.

Yates C, Long MD, Campbell MJ, Sucheston-Campbell L.

Front Biosci (Landmark Ed). 2017 Jan 1;22:212-229. Review.

47.

The Impact of Ostomy on Quality of Life and Functional Status of Crohn's Disease Patients.

Abdalla MI, Sandler RS, Kappelman MD, Martin CF, Chen W, Anton K, Long MD.

Inflamm Bowel Dis. 2016 Nov;22(11):2658-2664.

48.

Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers.

Herfarth HH, Jackson S, Schliebe BG, Martin C, Ivanova A, Anton K, Sandler RS, Long MD, Isaacs KL, Osterman MT, Sands BE, Higgins PD, Lewis JD.

Inflamm Bowel Dis. 2017 Jan;23(1):14-22. doi: 10.1097/MIB.0000000000000907. Review.

49.

Reply to Dai et al.

Gaines LS, Kappelman MD, Long MD.

Am J Gastroenterol. 2016 Aug;111(8):1207-8. doi: 10.1038/ajg.2016.237. No abstract available.

PMID:
27481427
50.

Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.

Kochar B, Long MD, Shelton E, Young L, Farraye FA, Yajnik V, Herfarth H.

J Clin Gastroenterol. 2017 Jul;51(6):508-511. doi: 10.1097/MCG.0000000000000604.

Supplemental Content

Support Center